Vanguard Group’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $664K | Sell |
1,600,808
-237,115
| -13% | -$98.4K | ﹤0.01% | 3860 |
|
|
2025
Q1 | $1.15M | Sell |
1,837,923
-49,079
| -3% | -$30.6K | ﹤0.01% | 3672 |
|
|
2024
Q4 | $3.15M | Buy |
1,887,002
+2,429
| +0.1% | +$4.06K | ﹤0.01% | 3433 |
|
|
2024
Q3 | $3.43M | Buy |
1,884,573
+157,325
| +9% | +$286K | ﹤0.01% | 3400 |
|
|
2024
Q2 | $10.4M | Buy |
1,727,248
+160,784
| +10% | +$970K | ﹤0.01% | 2893 |
|
|
2024
Q1 | $17.5M | Buy |
1,566,464
+64,055
| +4% | +$714K | ﹤0.01% | 2672 |
|
|
2023
Q4 | $22.4M | Buy |
1,502,409
+494,173
| +49% | +$7.36M | ﹤0.01% | 2544 |
|
|
2023
Q3 | $4.84M | Buy |
1,008,236
+1,648
| +0.2% | +$7.91K | ﹤0.01% | 3262 |
|
|
2023
Q2 | $7.56M | Sell |
1,006,588
-28,951
| -3% | -$217K | ﹤0.01% | 3108 |
|
|
2023
Q1 | $4.68M | Sell |
1,035,539
-389,759
| -27% | -$1.76M | ﹤0.01% | 3339 |
|
|
2022
Q4 | $16.1M | Buy |
1,425,298
+14,289
| +1% | +$161K | ﹤0.01% | 2730 |
|
|
2022
Q3 | $13.5M | Buy |
1,411,009
+86,272
| +7% | +$826K | ﹤0.01% | 2809 |
|
|
2022
Q2 | $10.7M | Sell |
1,324,737
-350,919
| -21% | -$2.84M | ﹤0.01% | 2954 |
|
|
2022
Q1 | $28.3M | Sell |
1,675,656
-32,378
| -2% | -$547K | ﹤0.01% | 2591 |
|
|
2021
Q4 | $36.7M | Buy |
1,708,034
+28,506
| +2% | +$613K | ﹤0.01% | 2522 |
|
|
2021
Q3 | $124M | Buy |
1,679,528
+129,810
| +8% | +$9.59M | ﹤0.01% | 1863 |
|
|
2021
Q2 | $84.7M | Buy |
1,549,718
+192,610
| +14% | +$10.5M | ﹤0.01% | 2081 |
|
|
2021
Q1 | $100M | Buy |
1,357,108
+473,846
| +54% | +$34.9M | ﹤0.01% | 1946 |
|
|
2020
Q4 | $76.1M | Buy |
883,262
+237,880
| +37% | +$20.5M | ﹤0.01% | 1974 |
|
|
2020
Q3 | $24.4M | Buy |
+645,382
| New | +$24.4M | ﹤0.01% | 2357 |
|